MedTrace Logo

PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles

NCT03774849 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2023-12-01

Study results available
· View outcomes & findings →

Summary

Evaluation of the PicoWay™ Laser System With 730nm and Resolve™ Fusion Handpieces for Treatment of Benign Pigmented Lesions and Wrinkles.

Conditions

  • Benign Pigmented Lesions
  • Facial Wrinkles

Interventions

DEVICE

PicoWay™ 532nm fractional handpiece

PicoWay™ Laser System is picosecond 532/1064/785 laser

DEVICE

PicoWay™ 730nm wavelength

PicoWay™ Laser System is picosecond 532/1064/785 laser

DEVICE

PicoWay™ 1064nm fractional handpiece

PicoWay™ Laser System is picosecond 532/1064/785 laser

Sponsors & Collaborators

  • Candela Corporation

    lead INDUSTRY

Principal Investigators

  • Joseph Lowery · Director of Clinical Affairs, Candela Corporation

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-05
Primary Completion
2020-11-12
Completion
2020-11-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03774849 on ClinicalTrials.gov